The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Artificial intelligence in drug development: present status and future prospects
Abstract
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process. At present, the pharmaceutical industry is facing challenges in sustaining their drug development programmes because of increased R&D costs and reduced efficiency. In this review, we discuss the major causes of attrition rates in new drug approvals, the possible ways that AI can improve the efficiency of the drug development process and collaboration of pharmaceutical industry giants with AI-powered drug discovery firms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [36]
Citations
Cites
Artificial intelligence in healthcare: past, present and future
Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000101 · Cited by 4,837
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Artificial intelligence in medicine
Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Deep Learning in Medical Imaging: General Overview
Lee, J., Jun, S., Cho, Y.-W., Lee, H., Kim, G. B., Seo, J. B., & Kim, N. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.4.570 · Cited by 1,328
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,000
Integration of artificial intelligence applications in clinical pharmacy services: A scoping review
Al‐Taie, A., Abdullah, A. S., & Arueyingho, O. (2026) · Future Healthcare Journal · doi:10.1016/j.fhj.2026.100547 · Cited by 1
Gonçalves, R. S., & Costa, E. V. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18080921 · Cited by 1
Mehmood, F., Asim, M. N., Mehmood, A., Mahmood, W., Vollmer, S. J., Haq, M. U., Ali, F., & Dengel, A. R. (2026) · Results in Engineering · doi:10.1016/j.rineng.2026.112449 · Cited by 2
Raj, A., Hasan, M., & Shahadat, S. B. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101783 · Cited by 1
Artificial intelligence in healthcare
Shah, Y., Soni, S., & Patel, M. P. (2021) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/j.ijpp.2021.018 · Cited by 2
Advanced Technologies in Health and Neurodegenerative Diseases
Naziris, N., & Demetzos, C. (2021) · Springer eBooks · doi:10.1007/978-3-319-75479-6_37-1 · Cited by 1
Shyr, Z. A., Cheng, Y., & Zheng, W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00058-x · Cited by 1
Advances in drug development with the application of artificial intelligence
Leite, M. S., de Jesus, A. A., Araújo, P. J. L., & dos Santos, B. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822248-5.00014-0 · Cited by 1
Reformation of the Healthcare Sector With Innovation and Entrepreneurial Approaches
Yadav, S. S., Mazumder, S. S., Arora, N., Santoshi, S., & Chauhan, V. (2022) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-6684-2508-4.ch011 · Cited by 1
Deshmukh, R., & Pasumarti, S. S. (2023) · Lecture notes in networks and systems · doi:10.1007/978-981-99-0769-4_48 · Cited by 1
Artificial neural network–based inference of drug–target interactions
Melamane, S., Mandava, T. T., Manda, A., Luphade, L. N., Khamanga, S. M., Makoni, P. A., Demana, P. H., Matafwali, S. K., & Witika, B. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91763-6.00015-1 · Cited by 2
Belsare, M. H., & Burušić, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-2909-2_17 · Cited by 1
Artificial Intelligence in Phycochemicals Recognition
Dullius, A., Buffon, G., Faria, M., & Giuliatti, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-42026-9_5 · Cited by 1
Vrushant, O., Prajapati, A. P., Patel, M. B. S., Narkhede, S. B., & Luhar, S. (2023) · EPRA International Journal of Research & Development (IJRD) · doi:10.36713/epra15249 · Cited by 1
Artificial Intelligence in Pharmaceutical Industry
Bodade, S. M., Mam, N. B., Deshmukh, D. S., Khedkar, S., & Hire, M. (2023) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-14346 · Cited by 1
Bai, J., Ni, Y., Zhang, Y., Wan, J., Liang, L., Qiao, H., Zhu, Y., Zhao, Q., & Li, H. (2024) · Current Computer - Aided Drug Design · doi:10.2174/0115734099277605231218071503 · Cited by 1
Potential of Artificial Intelligence in Healthcare Sector
Khurana, S., Malik, A., Narwal, S., Agarwal, G., & Sangwan, K. (2024) · International Conference on Computational Intelligence and Computing Applications (ICCICA) · doi:10.1109/iccica60014.2024.10584926 · Cited by 1
Chatterjee, J., Neogi, S. G., & Saraswat, S. (2024) · Lecture notes in networks and systems · doi:10.1007/978-981-97-2550-2_26 · Cited by 1
Reflections on “Can AI Understand Our Universe?”
Wang, Y. (2024) · International Journal of Modern Physics D · doi:10.1142/s0218271825400103 · Cited by 1
Paringamalai, N., Tajudeen, S. S., Ibrahim, A. M., Ahmed, J., Ramalingam, K., & Vijayakumar, S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107213 · Cited by 1
Revolutionizing Drug Development: Harnessing Artificial Intelligence in Pharmaceutical Sciences
Roy, S. P., Kadiri, S. K., Bhowmik, S., Patel, V., Deb, L., & Tiwari, P. K. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638343448250207053913 · Cited by 2
Jackson, P. J., & Thurston, D. E. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012898-00057 · Cited by 1
Translational science: Key features, issues and future perspectives
Kurebayashi, Y. (2019) · Translational and Regulatory Sciences · doi:10.33611/trs.1_1 · Cited by 1
Personalized biomedicine in cancer: from traditional therapy to sustainable healthcare
Ulu, G. T., Kiraz, Y., & Baran, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819541-3.00022-0 · Cited by 1
Artificial Intelligence-Enabled Prognosis Technologies for SARS-CoV-2/COVID-19
Mishra, A. B., Shukla, D., Aich, S., Singh, R., Mishra, S., Roy, B., Singh, P. P., Mishra, A., & Saxena, S. K. (2021) · Medical virology · doi:10.1007/978-981-15-7317-0_9 · Cited by 1
Analysis of floor stability in underground coal mines
Santos, C. A. (1988) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 1
(2020) · Asia-Pacific Biotech News · doi:10.1142/s021903032000110x · Cited by 1
Integrative Bioinformatics: History and Perspective
Chen, M., Hofestädt, R., & Taubert, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-6795-4_1 · Cited by 1
A Review on an Artificial Intelligence Based Ophthalmic Application
Kothandan, S., Radhakrishnan, A., & Kuppusamy, G. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220520112240 · Cited by 1
Artificial Intelligence and Machine Learning Approach towards COVID-19
Chavali, M. S. (2020) · Nanomedicine & Nanotechnology Open Access · doi:10.23880/nnoa-16000201 · Cited by 1
ARTIFICIAL INTELLIGENCE - REVOLUTIONIZING CLINICAL TRIAL PROCESS
(2022) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2022/11.12.6545 · Cited by 1
An Optimized Cloud Computing Method for Extracting Molecular Descriptors
Didachos, C., Kintos, D.-P., Fousteris, M. A., Phivos Mylonas, B., & Kanavos, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31982-2_28 · Cited by 1
Applications of Artificial Intelligence in Pharmaceutical Industries
Choudhary, H., Sharma, A., & Ahuja, D. (2023) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2023.v81i01.027 · Cited by 1
Rathore, S., & Dahiya, P. (2024) · Journal of Health Management · doi:10.1177/09720634241278878 · Cited by 1
Artificial Intelligence Technologies in Healthcare
Bayğın, M. (2025) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-83549-676-320251004 · Cited by 1
The Next Big Developments – The Lab of the Future
Shute, R. E., & Lynch, N. (2021) · Wiley eBooks · doi:10.1002/9783527825042.ch1 · Cited by 1
Role of Medical Image Analysis in Oncology
Kaur, G., Hardik, G., Heena, K., Singh, L., Kaur, N., Kumar, S., & Alam, S. (2021) · doi:10.1002/9781119711278.ch12 · Cited by 1
In Silico Design and Selection of CD44 Antagonists
Ruiz-Moreno, A. J. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.193912062 · Cited by 1
S, B. G. A., Madaj, R., Valluri, P. P., & Sanker, A. (2021) · doi:10.31219/osf.io/b8y79 · Cited by 1
Towards the development of machine learning models to predict protein-protein interaction modulatorsPreprint
Díaz‐Eufracio, B. I., & Medina‐Franco, J. L. (2022) · ChemRxiv · doi:10.26434/chemrxiv-2022-jz75v · Cited by 1
Recent Advances in Drug Design With Machine Learning
Faisal, M. (2022) · Wiley eBooks · doi:10.1002/9781394167258.ch6 · Cited by 1
Lu, X., Chen, M., Lu, Z., Shi, X., & Liang, L. (2023) · Research Square · doi:10.21203/rs.3.rs-3217391/v1 · Cited by 1
Toward Out-of-Domain Binding Affinity PredictionPreprint
Zhao, Z., Fang, S., & Wang, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3675013/v1 · Cited by 1
ClinMED-LLAMA3 A Large Model of Clinical Medicine Based on LLAMA3Preprint
Wei, M., & Liu, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4703651/v1 · Cited by 1
Special Issue “Drug Discovery and Application of New Technologies”
Hu, S., Li, Y., & Hu, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111756 · Cited by 1
Resolving AI Value Paradox: Unlocking AI's Value Through Strategic Knowledge IntegrationPreprint
Gao, K., Son, Y., & Yoo, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5019708 · Cited by 2
Modeling Protein-Ligand Interactions: Are We Ready for Deep Learning?
Rognan, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11521-1
AI-assisted inventions in the field of drug discovery: readjusting the obviousness analysis
Gurgula, O. (2020) · International Journal of Social Science and Public Policy · doi:10.33642/ijsspp.v2n8p2
Design and Develop a Web-application for Providing Pharmaceutical Product Leaflets Information
Al-Muhaisen, H., Alzuabi, A. F. F., Alshammari, H. A. A., Alghamdi, R. K. S., Tayfour, M. F., & Hawamdeh, E. A. (2020) · International Journal of Scientific Research in Science and Technology · doi:10.32628/ijsrst207319
Madaj, R., S, B. G. A., Sanker, A., & Valluri, P. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.11.421768
N-of-1 trials: Implications for clinical practice and personalized clinical trials
Bradbury, J., & Mähler, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820239-5.00008-5
Volkova, S., Hodas, N. O., & Scheibe, T. (2021) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/1769670
Naz, S., Khan, M. I., Shah, S. A., & Qayyum, A. (2021) · Humanities & Social Sciences Reviews · doi:10.18510/hssr.2021.9238
Practical Applications of Artificial Intelligence for Disease Prognosis and Management
Chaurasia, A., Vats, S., Sengupta, A., Bansal, A., & Narad, P. (2021) · Springer eBooks · doi:10.1007/978-981-16-0811-7_1 · Cited by 1
Montagna, D. M., Fino, E., Nocera, G., & Amendola, A. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3755675
Vpliv izobrazbene strukture razvojnega oddelka na uspešnost organizacije
Leskovec, F., & Černe, M. (2020) · Economic and business review · doi:10.15458/2335-4216.1031
Swamy, C. T. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.3.52
LOE: principios generales y finalidades del sistema educativo
Nájera, P. M. U. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Rajagopalan, V., & Cao, H. (2021) · Advances in computational intelligence and robotics book series · doi:10.4018/978-1-7998-8455-2.ch004
Novel Corona Virus (COVID-19): Current Strategies and Future Aspects
(2021) · Letters in Applied NanoBioScience · doi:10.33263/lianbs114.42014212
Target-less Drug Discovery Pipeline using Feature Driven Development (FDD) model
Chandra, R., Javed, M., Rajesh, B., Sanjeev, B. S., & Khijmatgar, S. (2021) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm52615.2021.9669585
Yadav, S. L., Dhaiya, R., & Bhatia, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90959-4.00006-7
STROJOVÉ UČENÍ, UMĚLÁ INTELIGENCE A VĚDA O DATECH V BOJI S PANDEMIÍ COVID-19
Hendl, J. (2021) · Medsoft · doi:10.35191/medsoft_2021_1_33_11_13
(2022) · Chemistry International · doi:10.1515/ci-2022-0100
Post COVID-19 Intelligent Public Healthcare Management
Bristy, A. T., Ferdousi, R., Hossain, A., Islam, M. M. F., Hossain, M. A., & Saddik, A. E. (2021) · IEEE Globecom Workshops (GC Wkshps) · doi:10.1109/gcwkshps52748.2021.9682056
Topical Repute on Artificial Intelligence-Based Approaches in COVID-19 Supervision
Basu, S., & Shafi, J. (2022) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-6684-3791-9.ch008
Jain, P., Mohapatra, S., Hassan, N., Singh, M., Farooq, U., Mirza, M. A., & Iqbal, Z. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815050561122010009
Artificial Intelligence and its Application in Cancer Nanomedicine
Mohanty, S., Acharya, S., & Mohanty, C. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815050561122010006
Translating Data Science Results into Precision Oncology Decisions: A Mini Review
Capobianco, E., & Dominietto, M. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020438
Data Mining and Machine Learning over HPC Approach Enhancing Antibody Conformations Prediction
Zanfack, D. R. G., Bellaiche, A., Etchebest, C., Dhiman, S. S., Gadhamshetty, V. R., Bomgni, A. B., & Gnimpiéba, E. Z. (2023) · ACS symposium series · doi:10.1021/bk-2023-1434.ch005
Hull, R., Manabile, M. A., & Dlamini, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-21506-3_11
Artificial intelligence and machine learning in Leishmania drug discovery
Diéguez‐Santana, K., Mazón-Ortiz, G., Mejía, G. L. C., & Ruso, J. M. (2022) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-08-13888
Geometric and topological AI for molecular sciences
Wee, J. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/165903
The Emergence of a Pharma Repurposing Ecosystem: Evidence of a New Innovation Strategy?Preprint
Barlow, J. G., Andriani, P., & Spyridonidis, D. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4483037
Advanced Technologies in Health and Neurodegenerative Diseases
Naziris, N., & Demetzos, C. (2023) · Springer eBooks · doi:10.1007/978-3-319-75922-7_37
Inteligencia artificial en enfermedades infecciosas
Belloso, W. H., Pasterán, F. G., Burgos, V. L., Díaz, S. A., Ciabis, V., & Risk, M. R. (2023) · Actualizaciones en Sida e Infectología · doi:10.52226/revista.v31i112.209
Artificial Intelligence used in Pharmaceutical and Healthcare Industry: A Review
Goswami, S., & Singh, M. K. (2023) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-12471 · Cited by 2
Ensemble Application of Fuzzy Multicellular Gene Expression by Programming Algorithm
Yuan, C. Q., Li, H., Zhang, Y., & Gong, D. (2023) · IEEE Eurasia Conference on Biomedical Engineering, Healthcare and Sustainability (ECBIOS) · doi:10.1109/ecbios57802.2023.10218445
AN OVERVIEW OF ARTIFICIAL INTELLIGENCE AS TOOL FOR DRUG DESIGN TO TREAT INFECTIOUS DISEASE
Astalakshmi, N., Keerthi Vasan, P., Harini, C., Parameshwari, B., Sridhar, R., Premkumar, N., Karthik, R., Kaviya, K., Sakthi, P., & Kumar, S. (2023) · Journal of Population and Therapeutics and Clinical Pharmacology · doi:10.53555/jptcp.v30i5.2635
George, S. A., & Bhadran, S. (2023) · doi:10.22192/ttdls.2023.007
Value Added Products from Mushroom – Need for the Hour
Pallavi, E., & Sheeba, E. (2023) · doi:10.22192/ttdls.2023.001
Role of diet and Nutrition in Enhancing sporting performance
Vijayanand, D. S. (2023) · doi:10.22192/ttdls.2023.008
Phytochemicals and their Functional Aspects
Ramojwar, J. (2023) · doi:10.22192/ttdls.2023.005
Nano bio-pesticides in sustainable agriculture
Deepa, V. H., & Prakash, N., V (2023) · doi:10.22192/ttdls.2023.006
Deepa, V. H. (2023) · doi:10.22192/ttdls.2023.003
Application of Artificial Intelligence in Biochemistry
Inbavalli., K. (2023) · doi:10.22192/ttdls.2023.015
Ekanayake, A. K., Ekanayake, A. K., & Gupta, N. (2023) · doi:10.22192/ttdls.2023.009
Meeting the Unmet Challenges of Pharmaceutical Research Using Artificial Intelligence
Mehrotra, S., & Pathak, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2302-1_4
THE ERA OF ARTIFICIAL INTELLIGENCE AND BIG DATA: A PATHWAY TO PHARMA 4.0
(2023) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2023/12.10.1018
Role of artificial intelligence in optimization of drug formulation
Rajan, J., Rajan, V., Sharma, R., & Sharma, R. K. (2023) · AIP conference proceedings · doi:10.1063/5.0143633
Bakhsh, T., Saleh, T. S., Al-Saedi, D. A., & Al-Zaydi, K. M. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03164-1
Predictive Modeling of Diseases with Explainable Artificial Intelligence Using LightGBM
Özdoğru, E. B., Santur, Y., & Ulaş, M. (2023) · International Journal of Advanced Natural Sciences and Engineering Researches · doi:10.59287/as-ijanser.10
How artificial intelligence is revolutionizing precision medicine and drug discovery?
Yousefi, A., Zandi, A., Shojaeian, F., Marzban, M. R., Tavakol, M. R., Abiri, H., Hojabri, M., Kaviani, G., & Pournezhad, S. (2023) · Iranian Journal of Blood and Cancer · doi:10.61186/ijbc.15.3.42
A COMPREHENSIVE REVIEW: EXPLORING ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY AND DEVELOPMENT
(2024) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets48342
Metadata
- Authors
- Mak, K.-K., & Pichika, M. R.
- Affiliations
- IMU University (MY)
- Corresponding author
- Pichika, Mallikarjuna Rao
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 24
- Issue
- 3
- Pages
- 773-780
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2901411193
- Cited by
- 1,018
- References
- 73
- Citations by year
- 2026: 161 · 2025: 196 · 2024: 190 · 2023: 170 · 2022: 99 · 2021: 119 · 2020: 63 · 2019: 18
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Funders
- International Medical University
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
- Keywords
- artificial intelligence, drug development, drug discovery, attrition rates, research and development costs, pharmaceutical industry
- MeSH terms
- Artificial Intelligence, Drug Industry, Humans, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review